Financhill
Back

Akero Therapeutics Vs. Blueprint Medicines Industry Stock Comparison

Sell
38

AKRO
Akero Therapeutics

Last Price:
$25.11
Seasonality Move:
-13.92%
Sell
45

BPMC
Blueprint Medicines

Last Price:
$110.07
Seasonality Move:
4.12%
Sell
38
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $25.14. The Score for AKRO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $110.05. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $25.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $110.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 41.89 Sell
Chaikin Money Flow: 466777 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.87 - 29.69) Sell
Bollinger Bands (100): (26.39 - 31.41) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.15 Buy
Relative Strength Index (14 RSI): 69.84 Buy
Chaikin Money Flow: 891346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.35 - 99.95) Buy
Bollinger Bands (100): (86.7 - 97) Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.2 Buy
20-day SMA: 26.69 Sell
50-day SMA: 29.44 Sell
200-day SMA: 25.88 Sell
8-day EMA: 24.51 Buy
20-day EMA: 26.24 Sell
50-day EMA: 28.03 Sell
200-day EMA: 27.58 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.66 Buy
20-day SMA: 93.45 Buy
50-day SMA: 94.81 Buy
200-day SMA: 97.03 Buy
8-day EMA: 101.17 Buy
20-day EMA: 96.44 Buy
50-day EMA: 94.26 Buy
200-day EMA: 92.14 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and an increase next year of $0.23 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.89 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):